Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Lupin

    Tag: lupin

    You Searched For "Lupin"
    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Farhat Nasim7 Jan 2019 9:45 AM IST
    Lupin's Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg is the generic version of Sunovion Pharmaceuticals, Inc's Latuda...
    Lupin receives FDA approval for Clobazam Oral Suspension

    Lupin receives FDA approval for Clobazam Oral Suspension

    Farhat Nasim1 Jan 2019 10:00 AM IST
    Lupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

    Medical Dialogues Bureau24 Dec 2018 9:30 AM IST
    Mumbai: Pharma major Lupin and global biopharmaceutical company AbbVie Inc., announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated...
    Lupin launches generic Tetrabenazine Tablets

    Lupin launches generic Tetrabenazine Tablets

    Medical Dialogues Bureau22 Nov 2018 4:26 PM IST
    Mumbai: Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food...
    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    Medical Dialogues Bureau23 Sept 2018 12:39 PM IST
    Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
    Lupin gets USFDA nod to market Tetrabenazine tablets

    Lupin gets USFDA nod to market Tetrabenazine tablets

    Ruby Khatun Khatun24 April 2018 10:15 AM IST
    New Delhi: Drug firm Lupin said it has received approval from the US health regulator to market in America its Tetrabenazine tablets used for the...
    HC Rescues Lupin on Price cap on powdered form of asthma drug

    HC Rescues Lupin on Price cap on powdered form of asthma drug

    Ruby Khatun Khatun22 April 2018 11:58 AM IST
    New Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
    Lupin gets USFDA nod for generic contraceptive tablets

    Lupin gets USFDA nod for generic contraceptive tablets

    Ruby Khatun Khatun15 Dec 2017 10:30 AM IST
    New Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
    Lupin Foundation aims to open 2 lakh bank accounts by 2020 in Rajasthan

    Lupin Foundation aims to open 2 lakh bank accounts by 2020 in Rajasthan

    Ruby Khatun Khatun2 Dec 2017 10:45 AM IST
    Bharatpur: Lupin Human Welfare and Research Foundation, part of pharma major Lupin, will facilitate opening over 2 lakh bank accounts through its...
    Lupin gets warning letter from USFDA for Goa, Indore plants

    Lupin gets warning letter from USFDA for Goa, Indore plants

    Ruby Khatun Khatun17 Nov 2017 11:00 AM IST
    New Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms...
    Lupin gets USFDA nod for generic version of Clobex lotion

    Lupin gets USFDA nod for generic version of Clobex lotion

    Ruby Khatun Khatun27 Sept 2017 12:43 PM IST
    New Delhi: Drug maker Lupin said it has received approval from the US health regulator to market anti-inflammatory Clobetasol Propionate lotion in the...
    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Ruby Khatun Khatun19 Sept 2017 10:29 AM IST
    Mumbai: Pharma Major Lupin announced the appointment of Jim Loerop as Chief Corporate Development Officer. Jim will lead Lupin's overall corporate...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok